Fractal Analytics Ltd Q4 FY2026 Concall Summary

Source transcript PDF: https://www.stockscans.in/document/1nfjhux0pnkpevnx3449cc0f.pdf

Key Takeaways


Enterprise AI Opportunity & Strategic Positioning

Srikanth Velamakanni: "The moment in front of us, frontier intelligence, agentic capability, and the transformation phase of enterprise AI is exactly the moment we have been spending decades preparing for."

Revenue Performance & Vertical Dynamics

VerticalFY26 GrowthCommentary
Healthcare & Life Sciences▲ 66%Became second-largest vertical on quarterly run rate; selected as strategic execution partner by a top-five US life sciences company for two flagship AI companions.
BFS▲ 32%Strong growth, no specific headwinds flagged.
CPG & Retail▲ 12%First-half weakness from Liberation Day trade regime freeze and inflation expectations; those issues have eased, and CPG is expected to do better.
TMT▼ –1% (Q4 –19%)Three discrete client issues: an APAC client’s JV moved business away; an enterprise software company restructured; a MAG-7 engagement delayed on data-related issues, preventing Q4 revenue recognition. Client-specific, not structural; improvement expected.
Europe▲ 34%Led geography performance.
Americas▲ 20%Solid growth.
APAC▼ –3% (Q4 turned to +7%)Dragged by the same TMT client issues; Q4 already turned positive.
Srikanth Velamakanni: "Literally every aspect of a business is up for re-imagination and rebuilding. That is what we are seeing."

Margins & Profitability

Margin walk (Q4 YoY)Impact
Mix shift to output-based contracts, price increases, productivity+151 bps
Weaker rupee+219 bps
Annual merit increase–322 bps
Net gross margin change → 48.2%+47 bps
Srikanth Velamakanni: "That drag is getting lifted as we speak, and Qure will have a much better year and also not contribute to additional losses to Fractal."

Revenue Model Shift: Outcome, Output & License


Platform, Products & Partnerships


Guidance & Commitments

CommitmentSpecificsTimeline
Revenue model shiftOutput-, outcome-, and license-based revenue to reach 60% of total (from ~40% today)Within 2–3 years
License revenue targetLicense-driven revenue to grow from 3% to 20% of totalBy 2030
TMT vertical recoveryClient-specific issues expected to have worked themselves out; expect to do betterNext few quarters
Qure.ai profitabilityQure will not contribute additional losses to Fractal; strong order book supports recoveryFY27
Fractal Alpha revenue contributionRevenue contribution will be higher than the prior yearFY27
Gross margin expansionContinue expanding gross margins while increasing revenue growth rate, not by sacrificing marginsOngoing
CPG and all verticalsExpected to do better across every verticalFY27

Key Metrics

MetricQ4 FY26
Revenue₹886 cr, +17% YoY and +4% QoQ
Full-year revenue₹3,300 cr, +19% YoY
Constant currency revenue growth10% YoY and 1.1% QoQ
Gross margin48.2%, expanded 47 bps YoY; mix shift and currency offset wage hikes
Adjusted EBITDA margin22.1%, expanded 189 bps YoY; included 147 bps from grant benefit and variable pay adjustments that may not repeat
Full-year adjusted EBITDA margin17.6%, versus 17.4% in FY25; includes 4.1% of revenue expensed on R&D
Net income₹116 cr, +109% YoY; net income margin expanded 575 bps YoY to 13.1%
Diluted EPS₹6.73, +106% YoY; ₹7.14 excluding losses from associate
Operating EBIT₹144 cr, +53% YoY (excluding other income, associate losses, and exceptional items)
Cash from operations₹409 cr for FY26, 70% conversion of adjusted EBITDA; DSO improved to 72 days from 74
Cash and equivalents₹2,052 cr as of March 31, 2026, including ₹957 cr IPO proceeds; debt repaid in April 2026
Net revenue retention112% for Q4; 117% for full year
Net promoter score81, highest recorded; full year NPS 78
Revenue per billable employee₹75 lakh, +5% in rupee terms for FY26
Clients with $1 mn+ revenue59 for FY26, up from 53 in FY25
Healthcare & life sciences growth66% for FY26, now second-largest vertical on quarterly run rate
CPG & retail growth12% for FY26, modest mainly on first-half weakness; remains largest vertical at 37% of revenue
TMT growth-19% in Q4; -1% for FY26 on client-specific issues
Fractal Alpha segment revenue growth41% for FY26; Asper grew 31%, Analytics Vidhya grew 49%
Fractal Alpha segment loss₹15 cr for FY26, narrowed from ₹26 cr in FY25
R&D spend₹212 cr for FY26, 48% higher than FY25; ₹134 cr expensed in P&L
ESOP charges1.8% of revenue in Q4, down from 3.3% in Q4 FY25
License-driven revenue share~3% of total revenue; target 20% by 2030
Output/outcome/license-based revenue share~40% currently; target 60% in next two to three years